These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11916619)

  • 1. A randomised controlled clinical trial of antibiotic impregnation of testosterone pellet implants to reduce extrusion rate.
    Kelleher S; Conway AJ; Handelsman DJ
    Eur J Endocrinol; 2002 Apr; 146(4):513-8. PubMed ID: 11916619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants.
    Kelleher S; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):531-6. PubMed ID: 11678837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrusion of testosterone pellets: a randomized controlled clinical study.
    Kelleher S; Turner L; Howe C; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):469-71. PubMed ID: 10583314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone release rate and duration of action of testosterone pellet implants.
    Kelleher S; Howe C; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous testosterone pellet implant (Testopel) therapy for men with testosterone deficiency syndrome: a single-site retrospective safety analysis.
    Cavender RK; Fairall M
    J Sex Med; 2009 Nov; 6(11):3177-92. PubMed ID: 19796052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of testosterone implants for androgen replacement therapy.
    Handelsman DJ; Mackey MA; Howe C; Turner L; Conway AJ
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):311-6. PubMed ID: 9373452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with the "V" implantation technique vs. standard technique for testosterone pellet therapy.
    Conners W; Flinn K; Morgentaler A
    J Sex Med; 2011 Dec; 8(12):3465-70. PubMed ID: 21883944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of testosterone pellets in man.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1990 Jul; 71(1):216-22. PubMed ID: 2115044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency.
    McMahon CG; Shusterman N; Cohen B
    J Sex Med; 2017 Jul; 14(7):883-890. PubMed ID: 28673432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion.
    McCullough AR; Khera M; Goldstein I; Hellstrom WJ; Morgentaler A; Levine LA
    J Sex Med; 2012 Feb; 9(2):594-601. PubMed ID: 22240203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive efficacy of a depot progestin and androgen combination in men.
    Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Pellet Implantation Practices: A Sexual Medicine Society of North America (SMSNA) Member Questionnaire.
    Piecuch MJ; Patel BG; Hakim L; Wang R; Sadeghi-Nejad H
    J Sex Med; 2017 Jan; 14(1):47-49. PubMed ID: 27989489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
    Kaminetsky JC; Moclair B; Hemani M; Sand M
    J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection rates of rifampin/gentamicin-coated Titan Coloplast penile implants. Comparison with Inhibizone-impregnated AMS penile implants.
    Dhabuwala C; Sheth S; Zamzow B
    J Sex Med; 2011 Jan; 8(1):315-20. PubMed ID: 20946163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
    Fennell C; Sartorius G; Ly LP; Turner L; Liu PY; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):102-9. PubMed ID: 19891698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
    Pastuszak AW; Mittakanti H; Liu JS; Gomez L; Lipshultz LI; Khera M
    J Androl; 2012; 33(5):927-37. PubMed ID: 22403285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of androgen deficiency and replacement on prostate zonal volumes.
    Jin B; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone Pellet Associated Dermatitis: Report and Review of Testopel-related Cutaneous Adverse Effects.
    Heldt Manica LA; Cohen PR
    Cureus; 2017 Aug; 9(8):e1560. PubMed ID: 29034138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.